PPD? Biotech Solutions has been on the leading edge of bringing value to emerging biotech and pharma companies. Our mindset is to simplify your drug development journey by combining hands-on attention and flexibility with global reach and end-to-end expertise. We can simplify your journey without sacrificing quality or reliability. We can support you at any point in your journey, whether you are starting in early phase all the way through post-approval and commercialization. Connect with us to advance your asset development!
PPD? Biotech Solutions的外部链接
Don't miss Doug Ahrens today at #OCTSoCal!
Will we see you at #OCTSoCal? Are you interested to uncover the CRDMO advantage in drug development? Doug Ahrens is presenting at 9:30 a.m. PT on Tuesday, Sept. 24 – and afterward, stop by booth 51 to chat with our team!
We’re so excited to be at #OCTSoCal this week. Learn more about our end-to-end #clinicaltrial outsourcing solutions by visiting booth 51. In the meantime, check out our integrated offerings. ? https://bit.ly/3XDcW1K
David Frakes, MD is joining a team of biotech industry executives, investors and scientists to climb Mt. Kilimanjaro this month in support of the Damon Runyon Cancer Research Foundation. Since 1946, scientists supported through the foundation have made breakthrough discoveries that have transformed our understanding of cancer and developed new approaches to prevention, diagnosis and treatment. We're with you every step of this journey, Dave! #WorldCancerDay
Mega-trials – enrolling 5,000 participants or more to demonstrate clinical efficacy of prophylactic vaccines – are rare in comparison with the large number of interventional vaccine clinical trials that are conducted. In this Drug Discovery & Development article, Paul Gillard provides an overview of vaccine mega-trials conducted over the last 20 years. ? https://bit.ly/46kslX2 #vaccines #clinicaltrials #clinicalresearch